MNTA – A formal response to the FDA’s generic-Lovenox concerns will be submitted in early May 2008. Source: <a href="http://www.novartis.com/downloads/investors/sales-results/Q1-2008-IR-slides.pdf" target="_blank">http://www.novartis.com/downloads/investors/sales-results/Q1-2008-IR-slides.pdf</a> [page #27, top]